Laatste proeven

EudraCT Number: 2004-001183-41

Sponsor Protocol Number: D5899C00002

Start Date: 2005-02-14

Sponsor Name: AstraZeneca AB

Full Title: A 6-month, double-blind, double-dummy, randomised, parallel group, multicenter, efficacy and safety study of Symbicort® pMDI 2x160/4.5μg and 2x80/4.5μg bid compared to Formoterol Turbuhaler, Budes...

Medical condition: This is an application for a phase III study to be conducted in COPD patients.

Disease:	Version	SOC Term	Classification Code	Term	Level
			10010952

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: View results

EudraCT Number: 2004-002341-12

Sponsor Protocol Number: DEB-EPI-206

Start Date: 2005-02-14

Sponsor Name: Debiopharm SA

Full Title: Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients

Medical condition: Cystic fibrosis

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10011762		PT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: DE (Completed) GB (Completed) IT (Completed) BE (Completed)

Trial results: View results

EudraCT Number: 2004-004801-11

Sponsor Protocol Number: 04-081

Start Date: 2005-02-14

Sponsor Name: Zealand Pharma A/S

Full Title: A Phase II, Multicenter, Double-Blind, Efficacy, Safety, and Tolerability Study of ZP120 Administered as Short Term I.V. Infusion as Add-On Therapy in Patients with Subacute Decompensated Chronic H...

Medical condition: Subacute decompensated chronic heart failure NYHA Class III-IV

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-001754-92

Sponsor Protocol Number: AAE581C2201

Start Date: 2005-02-14

Sponsor Name: Novartis Pharma Services AG

Full Title: A phase II, 12-month, double-blind, placebo-controlled, dose-finding, multicenter study to evaluate the safety, tolerability, and disease modifying efficacy of daily oral AAE581 (10, 25 and 50 mg t...

Medical condition: Osteoarthritis (OA) is a disease with a complex pathophysiology leading to the degeneration of articular cartilage and bone. It is characterized by pain, biochemical and enzymatic changes, cartilag...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-002859-13

Sponsor Protocol Number: SAKK 35/03

Start Date: 2005-02-14

Sponsor Name: SIAK

Full Title: Comparing two schedules of rituximab maintenance in rituximab-responding patients with untreated, chemotherapy resistant or relapsed follicular lymphoma: A randomized phase III trial

Medical condition: rituximab-responding patients with untreated, chemotherapy resistant or relapsed follicular lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10025634		HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed) SK (Completed)

Trial results: (No results available)

EudraCT Number: 2004-003943-28

Sponsor Protocol Number: LAQ/5062

Start Date: 2005-02-14

Sponsor Name: Teva Pharmaceutical Industries Ltd

Full Title: A multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study, to evaluate the efficacy, tolerability and safety of two doses of laquinimod orally administered in...

Medical condition: Relapsing Remitting Multiple Sclerosis

Disease:	Version	SOC Term	Classification Code	Term	Level
	5.1		10028245		PT

Population Age: Adults

Gender: Male, Female

Trial protocol: HU (Completed) IT (Completed) CZ (Completed) GB (Completed) DE (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-002109-58

Sponsor Protocol Number: RSR13 RT-016

Start Date: 2005-02-14

Sponsor Name: ALLOS Therapeutics, Inc.

Full Title: A Phase 3 Randomized, Open-label Comparative Study of Standard Whole Brain Radiation Therapy with Supplemental Oxygen, with or without Concurrent RSR13 (efaproxiral), in Women with Brain Metastases...

Medical condition: Brain metastases from breast cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	4.0		10027453		4

Population Age: Adults, Elderly

Gender: Female

Trial protocol: AT (Completed) HU (Completed) GB (Completed) LT (Completed) ES (Ongoing) IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-001782-18

Sponsor Protocol Number: MRZ 92579-0404/1

Start Date: 2005-02-14

Sponsor Name: Merz Pharmaceuticals GmbH

Full Title: Saftey and efficacy of two different doses of Neramexane mesylate as preemptive analgesic and add-on therapy to opioids in the management of postoperative pain. A randomised, double-blind, placebo-...

Medical condition: Moderate to severe acute postoperative pain

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.1		10054711		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: View results

EudraCT Number: 2004-001072-39

Sponsor Protocol Number: BY9010/M1-142

Start Date: 2005-02-11

Sponsor Name: ALTANA Pharma AG

Full Title: Comparison of Ciclesonide (80 µg Once Daily in the Evening) and Fluticasone propionate (100 µg Twice Daily) in Patients with Mild to Moderate Asthma

Medical condition: bronchial asthma

Disease:	Version	SOC Term	Classification Code	Term	Level
	5.1		10003553		llt

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2004-004558-18

Sponsor Protocol Number: 20000178

Start Date: 2005-02-11

Sponsor Name: Amgen Inc

Full Title: A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Chronic Kidney Disease Subjects with Secondary Hyperparathyroidism Not Receiving Dialysis

Medical condition: Secondary Hyperparathyroidism in Chronic Kidney Disease subjects not receiving dialysis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Prematurely Ended) NO (Ongoing) DK (Completed) IT (Prematurely Ended) ES (Ongoing)

Trial results: (No results available)

Laatste proeven

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies